Efficiency and Tolerance of Second-Line Triple BRAF Inhibitor/mek Inhibitor/anti-Pd1 Combined Therapy in BRAF Mutated Melanoma Patients with Central Nervous System Metastases Occurring During First-Line Combined Targeted Therapy: a Real-Life Survey.
MELANOMA RESEARCH（2024）
关键词
CNS metastases,immunotherapy,melanoma,targeted therapy,tritherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要